Myristoyl Pentapeptide-17

Myristoyl Pentapeptide-17

Myristoyl Pentapeptide-17

Myristoyl pentapeptide-XVII est bioactive peptide specialiter disposita et summatim alloqui insufficiens incrementum ciliorum naturalium / capillorum.

 

 

SKU: 198854 Categoria:
Participes tui amoris

Myristoyl pentapeptide-XVII est a bioactive peptide nominatim disposito et summatim alloqui insufficiens incrementum cilia naturalis / capillos.

Ex a * 14-18 amino acid fragment of keratin-sosociated protein KAP5-1, subit N-terminatio myristoylation et C-terminalis amidation; hoc auget dimidium-vita, permittens enim recta penetratio hominum epidermal membranae cellulae.

Myristoyl pentapeptide-XVII est currently unus potentior medicamine peptides ad excitandam cilia incrementum, late incorporati sunt in numerosis pulchritudines products.

Sequentia

Myr-Lys-Leu-Ala-Lys-Lys-NH2

CAS Number

959610-30-1

Formulae hypotheticae

C41H81N9O6

M. Pondus

796.16

Myristoyl Pentapeptide-17 Related Research

1.Primae Mechanismi biologici

Improved partus efficientiam KGF(Keratinocyte Augmentum Factor), VEGF(Vascularis Endothelial Augmentum Factor) et lysophosphatidic acidum (LPA) facilius in his cellulis, et capillum incrementum exolvuntur.

Anti-inflammatoriae proprietates etiam exhibentur, idoneus sparsis superciliis, et quasi adiuncta curatio est androgeneticum alopecia; photoaging circum oculos esse primariam curam.

Promovere follicularis circulatio sanguinis est alius effectus clavem – auctus sanguis ad folliculos capillorum modo augetur nutrimentum et partus oxygenii, partum specimen nutritionis environment pro eyelash incrementum.

2.Upregulation of keratin gene expressio

Fragmentum activum de quo supra dictum est retinet nucleum functionis originalis KAP proteins(Keratin Associated interdum).

Binding to caonic amino acid transporters, transcription and subsequent synthesis of KAP5-1 and Type I keratins (31 esse maxime amet) est upregulated.

Crassitudo cortex pilorum est manifestatio corporis huius processus, eyelash mollitiam signanter auctus.

3.Promovere microcirculation/CIBUS copia

Myristoyl pentapeptide-17 excitat keratinocytes dimittere VEGF-A et basic fibroblast incrementum factors(bFGF or FGF2).

Celeri membrana penetratio ad microvessel dermal vasodilation, melius sanguis, auctus intercellulare nutrimentum commutatio augetur alimentorum copia ad folliculum.

Inflammatio effectus omnes anti-maioris partis sunt, processus cutis obice reparatione sui sustentans.

Abbreviatio requietionis capillorum folliculus et fovens cilia sanitatis, est finis actionum Myristoyl Pentapeptide-17 actionum.

COA

HPLC

MS

Sequentia:

Myr-Lys-Leu-Ala-Lys-Lys-NH2

CAS:

959610-30-1

M.W:

796.14 g / mol

Home Investigatio whatsapp Officia Productum